-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NwgJpj5qxEL9hgZFTfTQykC5bOO11juGcmPzvWWob+oj2xjDnZxHV/Z8YfiyrJLz rVivOck+d1MHrltqW+eQoQ== 0000950162-08-000089.txt : 20080213 0000950162-08-000089.hdr.sgml : 20080213 20080213145736 ACCESSION NUMBER: 0000950162-08-000089 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080213 DATE AS OF CHANGE: 20080213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43408 FILM NUMBER: 08603935 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CAVAZZA CLAUDIO CENTRAL INDEX KEY: 0001164803 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 CITY: ROME ITALY STATE: L6 ZIP: 00000 SC 13G/A 1 scicloneclaudo13gano5_021308.htm SCICLONE PHARMACEUTICALS/CLAUDIO CAVAZZA SCHEDULE 13G/A NO. 5 scicloneclaudo13gano5_021308.htm
 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13G/A5


Under the Securities Exchange Act of 1934
(Amendment No. 5)*

SciClone Pharmaceuticals, Inc.

(Name of Issuer)


Common Stock, Par Value $0.001 per share

(Title of Class of Securities)


80862K104

(CUSIP Number)


December 31, 2007

(Date of Event which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant
to which this Schedule is filed:
 
           o   Rule 13d-1(b)
           o   Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



 
 

 


1.
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
 
Claudio Cavazza
2.
Check the Appropriate Box if a Member of a Group
(See Instructions)                                                                                                                                                                       &# 160;                                                                                    (a) o
                                                                                                                                           &# 160;                                                                                                                                                (b) o
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization
 
Italy
 
5.
Sole Voting Power
 
394,615
Number of
Shares
Beneficially
6.
Shared Voting Power
 
6,394,988
Owned by Each
Reporting
Person With:
7.
Sole Dispositive Power
 
394,615
 
8.
Shared Dispositive Power
 
6,394,988
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
 
6,789,603 (as of December 31, 2007)
10.
Check box if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)                                                                                                                                                                       &# 160;                                                               o
 
11.
Percent of Class Represented by Amount in Row (9)
 
14.7% (based upon 46,114,562 shares of Common Stock outstanding as of October 31, 2007, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 filed with the U.S. Securities and Exchange Commission on November 9, 2007).
12.
Type of Reporting Person (See Instructions)
 
IN

 
-2-

 


Item 1(a).
Name of Issuer:

SciClone Pharmaceuticals, Inc.


Item 1(b).
Address of Issuer’s Principal Executive Offices:

901 Mariner’s Island Boulevard, Suite 205, San Mateo, CA 94404

Item 2(a).
Name of Person Filing:

Claudio Cavazza

Item 2(b).
Address of Principal Business Office:

Via Sudafrica, 20
Rome, Italy  00144


Item 2(c).
Citizenship:

Italian Citizen


Item 2(d).
Title of Class of Securities:

Common Stock, par value $0.001 per share (the “Shares”)

Item 2(e).
CUSIP Number:

80862K104

Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a:

This Item 3 is not applicable

 
-3-

 


Item 4.
Ownership:

(a)
Amount beneficially owned:
6,789,603
     
(b)
Percent of class:
14.7%
     
(c)
Number of shares as to which such person has:
 
 
(i)   sole power to vote or to direct the vote:
394,615
 
(ii)  shared power to vote or to direct the vote:
6,394,988
 
(iii)  sole power to dispose or to direct the disposition of:
394,615
 
(iv)   shared power to dispose or to direct the disposition of:
6,394,988


Item 5.
Ownership of Five Percent or Less of a Class:

Not Applicable

Item 6.
Ownership of More than Five Percent on Behalf of Another Person:

Not Applicable

Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

Not Applicable

Item 8.
Identification and Classification of Members of the Group:

Not Applicable

Item 9.
Notice of Dissolution of Group:

Not Applicable

Item 10.
Certification:

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


 
-4-

 

SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 13, 2008
CLAUDIO CAVAZZA


By:           /s/ Antonio Nicolai
Name:  Antonio Nicolai
Title: proxy holder authorized











This Schedule 13G was signed under a Power-of-Attorney incorporated by reference to Form 4s filed April 1, 2005


 
 
-5-
 
-----END PRIVACY-ENHANCED MESSAGE-----